Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma

Clinical trial NCT03396952 · COMPLETED

Trial details

NCT number: NCT03396952
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Cutaneous Melanoma Stage IIIA Cutaneous Melanoma Stage IIIB Cutaneous Melanoma Stage IIIC Cutaneous Melanoma Stage IV Cutaneous Melanoma

Start date: 2018-04-19
Primary completion: 2020-04-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.